Lassiter, M., & Lail, C. (2025). Omidubicel-Onlv: The First Commercially Available Alternative Allogeneic Hematopoietic Stem Cell Transplantation Donor Source. Clinical Journal of Oncology Nursing, 29(3), 230-237.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Lassiter, Martha, y Charlotte Lail. "Omidubicel-Onlv: The First Commercially Available Alternative Allogeneic Hematopoietic Stem Cell Transplantation Donor Source."
Clinical Journal of Oncology Nursing 29, no. 3 (2025): 230-237.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Lassiter, Martha, y Charlotte Lail. "Omidubicel-Onlv: The First Commercially Available Alternative Allogeneic Hematopoietic Stem Cell Transplantation Donor Source."
Clinical Journal of Oncology Nursing, vol. 29, no. 3, 2025, pp. 230-237.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.